‘Excessive pricing’ and pharmaceuticals – Law Society’s Gazette

Posted June 12th, 2017 in competition, markets, medicines, news, price fixing by sally

‘After years of limited focus on ‘excessive pricing’, in December 2016 the Competition and Markets Authority (CMA) took one decision finding that such an abuse of dominance had occurred, and issued a statement of objections in another case. Does this reflect a broad policy shift, or a reaction to specific cases of perceived opportunistic behaviour?’

Full Story

Law Society's Gazette, 12th June 2017

Source: www.lawgazette.co.uk